A detailed history of Knott David M Jr transactions in Ardelyx, Inc. stock. As of the latest transaction made, Knott David M Jr holds 825,000 shares of ARDX stock, worth $6.11 Million. This represents 2.13% of its overall portfolio holdings.

Number of Shares
825,000
Previous 1,380,000 40.22%
Holding current value
$6.11 Million
Previous $8.56 Million 29.6%
% of portfolio
2.13%
Previous 3.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$6.05 - $9.74 $3.36 Million - $5.41 Million
-555,000 Reduced 40.22%
825,000 $6.02 Million
Q4 2023

Feb 13, 2024

SELL
$3.29 - $6.64 $394,800 - $796,800
-120,000 Reduced 8.0%
1,380,000 $8.56 Million
Q4 2022

Feb 13, 2023

BUY
$1.22 - $2.85 $1.04 Million - $2.42 Million
850,000 Added 130.77%
1,500,000 $4.28 Million
Q3 2022

Nov 10, 2022

BUY
$0.59 - $1.44 $383,500 - $936,000
650,000 New
650,000 $774,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $1.15B
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Knott David M Jr Portfolio

Follow Knott David M Jr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

News

Stay updated on Knott David M Jr with notifications on news.